Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00633516 · ClinicalTrials.gov registry record
A Pilot Study to Evaluate Optical Spectroscopy of Pigmented Skin Lesions
A clinical trial, sponsored by University of California, Irvine.
- Completed
- Registry status
- 37
- Enrollment target
NCT00633516 is a clinical trial that has completed, run by University of California, Irvine. The registered enrollment target is 37 participants.
The verdict
NCT00633516 has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- 37 participants
- Enrollment target
Study Summary
The incidence of malignant melanoma has increased dramatically in recent decades. In 1930, the lifetime risk of an individual in the United States developing melanoma was 1 in 1,500. This has been exponentially increasing over the years with the risk estimated to be 1 in 75 in 2000 . According to the American Cancer Society, approximately 59,580 new cases of melanoma will be diagnosed in the United States in 2005 and about 7,770 people are expected to die of the disease.
Interventions
- DEVICE Optical Spectroscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2008-07 |
| Est. Completion | 2013-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00633516
The ClinicalTrials.gov registry entry for NCT00633516 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Optical Spectroscopy is the first listed.
NCT00633516 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00633516 about?
NCT00633516 is a clinical study titled "A Pilot Study to Evaluate Optical Spectroscopy of Pigmented Skin Lesions". The incidence of malignant melanoma has increased dramatically in recent decades. In 1930, the lifetime risk of an individual in the United States developing melanoma was 1 in 1,500. This has been exponentially increasing over the years with the risk estimated to be 1 in 75 in 2000 . According to th...
What is the current status of trial NCT00633516?
This trial is currently completed. The enrollment target is 37 participants. The study started on 2008-07. Estimated completion is 2013-11.
What interventions are being tested in trial NCT00633516?
The interventions under investigation include: Optical Spectroscopy (DEVICE).
Who is sponsoring clinical trial NCT00633516?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.